We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Join our healthcare community
Learn about Sanfilippo syndrome (MPS III), a rare genetic disorder affecting children. Understand its symptoms, types, causes, diagnosis, and management strategies.
Sanfilippo syndrome, also known as mucopolysaccharidosis (MPS) type III, is a rare, inherited metabolic disorder that primarily affects children. It is a type of lysosomal storage disorder, meaning that the body lacks specific enzymes needed to break down and recycle complex sugar molecules called heparan sulfates. When these molecules build up to high levels in the body, they can cause significant damage, particularly to the brain and central nervous system. This progressive condition is sometimes referred to as “childhood Alzheimer’s” due to the gradual loss of physical and mental development it causes over time.
The syndrome is inherited in an autosomal recessive pattern. This means that a child must inherit a faulty gene from both parents to develop the condition. If both parents are carriers of the gene, there is a 25% chance with each pregnancy that their child will have Sanfilippo syndrome, a 50% chance the child will be a carrier but unaffected, and a 25% chance the child will be neither affected nor a carrier.
There are four main types of Sanfilippo syndrome, each caused by a deficiency in a different enzyme and mutation in a specific gene:
Babies born with Sanfilippo syndrome may not show any signs at birth. Symptoms typically begin to appear when a child is between 2 and 5 years old, although early signs can sometimes be observed between 1 and 3 years old. The onset and progression of symptoms can vary significantly from child to child, and the condition is progressive, meaning its effects worsen over time. Symptoms can affect multiple body systems, physical features, and behaviors, ranging from mild to severe and potentially life-threatening.
While not always present or distinct in early stages, some physical characteristics may become more apparent as the condition progresses:
The central nervous system is heavily impacted by Sanfilippo syndrome:
As mentioned, Sanfilippo syndrome is caused by inherited genetic mutations that lead to a deficiency in specific enzymes responsible for breaking down heparan sulfate. These mutations are passed down from parents who are carriers of the faulty gene.
Diagnosing Sanfilippo syndrome typically involves a combination of clinical evaluation and specific laboratory tests:
Currently, there is no cure for Sanfilippo syndrome. Treatment focuses on managing symptoms and improving the child's quality of life. This often involves a multidisciplinary team of healthcare professionals.
Sanfilippo syndrome is a genetic disorder, and as such, it cannot be prevented. However, for families with a history of the condition or those who are known carriers, genetic counseling can provide valuable information about the risks of having a child with Sanfilippo syndrome and discuss options such as prenatal testing.
Parents should consult a pediatrician if they notice significant developmental delays in their child, particularly in areas of speech, motor skills, or cognitive development, especially between the ages of 1 and 5 years. Behavioral changes like extreme hyperactivity or persistent sleep problems, along with any unusual physical features or frequent infections, should also prompt a medical evaluation. Early diagnosis is crucial for initiating supportive care and managing symptoms effectively.
Life expectancy varies depending on the type and severity of Sanfilippo syndrome. Children with Type A often have a shorter life expectancy, sometimes not living past childhood or early adolescence. Other types may allow individuals to live into their late teens or early twenties, though this can vary greatly.
While Sanfilippo syndrome is sometimes called “childhood Alzheimer’s” due to the progressive cognitive decline it causes, it is a distinct genetic disorder. Alzheimer's disease is typically an age-related neurodegenerative condition, whereas Sanfilippo syndrome is a rare inherited metabolic disorder that affects children.
Currently, there is no cure for Sanfilippo syndrome. Treatment focuses on managing symptoms, providing supportive care, and improving the quality of life for affected children. Research into potential therapies, including enzyme replacement therapy and gene therapy, is ongoing.
Visit Hospital
Near You
Learn about Parkinson's disease symptoms, causes, stages, and treatment options. A complete guide for patients and caregivers in simple language.
June 13, 2026
Seeking a brain specialist in Kamarhati? Doctar connects you with leading neurologists and neurosurgeons for expert care. Book appointments now.
May 20, 2026
Find immediate medical attention at 24-hour hospitals in Kamarhati. Learn about emergency services, specialist availability, and when to seek help.
May 20, 2026